Agilent Technologies A Life Sciences and Diagnostics Markets — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Agilent Technologies in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Agilent Technologies’s 10-Q, filed June 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agilent Technologies's life sciences and diagnostics markets — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Agilent Technologies's life sciences and diagnostics markets — goodwill?
- Agilent Technologies (A) reported life sciences and diagnostics markets — goodwill of $3B in Q1 2026.
- How has Agilent Technologies's life sciences and diagnostics markets — goodwill changed year-over-year?
- Agilent Technologies's life sciences and diagnostics markets — goodwill decreased by 0.1% year-over-year, from $3B to $3B.
- What does life sciences and diagnostics markets — goodwill mean?
- This represents the intangible asset value recorded when the company acquires another business for a price exceeding the fair market value of its identifiable net assets. It reflects the premium paid for brand reputation, customer relationships, and intellectual property within the life sciences segment.